Inventor · disambiguated record
Christopher Breder
Also filed as: BREDER CHRISTOPHER · BREDER CHRISTOPHER D
56 granted patents·41 pending applications·1,878 citations·filing 2002–2025
99Inventor score
Files withPURDUE PHARMA LP70SUPERNUS PHARMACEUTICALS INC15BREDER CHRISTOPHER3WRIGHT CURTIS3BREDER CHRISTOPHER D2
Top patents by PatentIndex Score
97 records- 0199US9387174B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2015·Granted Jul 12, 2016·26 cites·22 claims
- 0299US9387173B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2015·Granted Jul 12, 2016·27 cites·22 claims
- 0399US9060976B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2012·Granted Jun 23, 2015·72 cites·1 claims
- 0499US9044435B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2014·Granted Jun 2, 2015·55 cites·20 claims
- 0599US9040084B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2013·Granted May 26, 2015·38 cites·9 claims
- 0699US9034376B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2014·Granted May 19, 2015·48 cites·19 claims
- 0799US8999961B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2013·Granted Apr 7, 2015·41 cites·8 claims
- 0899US8871265B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2014·Granted Oct 28, 2014·51 cites·13 claims
- 0999US8609683B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2013·Granted Dec 17, 2013·85 cites·22 claims
- 1099US8529948B1Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2013·Granted Sep 10, 2013·80 cites·22 claims
- 1199US8524275B2Pharmaceutical formulations containing opioid agonist, opioid antagonist and gelling agentOSHLACK BENJAMIN·Filed 2010·Granted Sep 3, 2013·92 cites·27 claims
- 1299US8389007B2Pharmaceutical composition containing gelling agentWRIGHT CURTIS·Filed 2008·Granted Mar 5, 2013·94 cites·20 claims
- 1399US8337888B2Pharmaceutical formulation containing gelling agentWRIGHT CURTIS·Filed 2012·Granted Dec 25, 2012·198 cites·24 claims
- 1499US7842307B2Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agentPURDUE PHARMA LP·Filed 2002·Granted Nov 30, 2010·221 cites·43 claims
- 1599US7144587B2Pharmaceutical formulation containing opioid agonist, opioid antagonist and bittering agentEURO CELTIQUE SA·Filed 2002·Granted Dec 5, 2006·216 cites·22 claims
- 1699US7141250B2Pharmaceutical formulation containing bittering agentPURDUE PHARMA LP·Filed 2002·Granted Nov 28, 2006·224 cites·38 claims
- 1798US9308171B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2015·Granted Apr 12, 2016·25 cites·24 claims
- 1898US9308170B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2013·Granted Apr 12, 2016·24 cites·17 claims
- 1997US8465774B2Sequestered antagonist formulationsBREDER CHRISTOPHER·Filed 2006·Granted Jun 18, 2013·52 cites·137 claims
- 2096US10206881B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2017·Granted Feb 19, 2019·7 cites·7 claims
- 2196US9872836B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2016·Granted Jan 23, 2018·8 cites·24 claims
- 2296US9693961B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2016·Granted Jul 4, 2017·7 cites·17 claims
- 2396US9101668B2Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agentPURDUE PHARMA LP·Filed 2013·Granted Aug 11, 2015·12 cites·22 claims
- 2495US10076497B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2016·Granted Sep 18, 2018·6 cites·22 claims
- 2595US10071057B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2016·Granted Sep 11, 2018·6 cites·25 claims
- 2695US10064824B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2016·Granted Sep 4, 2018·6 cites·26 claims
- 2795US9517207B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2015·Granted Dec 13, 2016·6 cites·24 claims
- 2894US8518443B2Opioid agonist formulations with releasable and sequestered antagonistBREDER CHRISTOPHER·Filed 2012·Granted Aug 27, 2013·22 cites·21 claims
- 2994US8231901B2Opioid agonist formulations with releasable and sequestered antagonistBREDER CHRISTOPHER·Filed 2011·Granted Jul 31, 2012·20 cites·20 claims
- 3094US7914818B2Opioid agonist formulations with releasable and sequestered antagonistPURDUE PHARMA LP·Filed 2002·Granted Mar 29, 2011·46 cites·21 claims
- 3193US9877924B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2016·Granted Jan 30, 2018·4 cites·19 claims
- 3293US9757341B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2016·Granted Sep 12, 2017·4 cites·20 claims
- 3392US10064825B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2017·Granted Sep 4, 2018·3 cites·13 claims
- 3490US2025009752A1Method of treatment of attention deficit/hyperactivity disorder (adhd)SUPERNUS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3589US10130586B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2016·Granted Nov 20, 2018·2 cites·20 claims
- 3689US8815287B2Opiod agonist formulations with releasable and sequestered antagonistPURDUE PHARMA LP·Filed 2013·Granted Aug 26, 2014·8 cites·21 claims
- 3788US11135171B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2019·Granted Oct 5, 2021·0 cites·20 claims
- 3888US10537526B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2018·Granted Jan 21, 2020·1 cites·7 claims
- 3988US10500160B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2018·Granted Dec 10, 2019·1 cites·13 claims
- 4086US7943173B2Pharmaceutical combinations of oxycodone and naloxonePURDUE PHARMA LP·Filed 2002·Granted May 17, 2011·27 cites·38 claims
- 4185US12121523B2Method of treatment of attention deficit/hyperactivity disorder (ADHD)SUPERNUS PHARMACEUTICALS INC·Filed 2022·Granted Oct 22, 2024·0 cites·29 claims
- 4285US9861583B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2016·Granted Jan 9, 2018·1 cites·7 claims
- 4385US8758825B2Sequestered antagonist formulationsPURDUE PHARMA LP·Filed 2013·Granted Jun 24, 2014·5 cites·22 claims
- 4484US9968559B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2016·Granted May 15, 2018·1 cites·20 claims
- 4584US9867784B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2016·Granted Jan 16, 2018·1 cites·17 claims
- 4684US9861582B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2016·Granted Jan 9, 2018·1 cites·22 claims
- 4783US11458143B2Method of treatment of attention deficit/hyperactivity disorder (ADHD)SUPERNUS PHARMACEUTICALS INC·Filed 2022·Granted Oct 4, 2022·0 cites·9 claims
- 4882US9867783B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2015·Granted Jan 16, 2018·1 cites·15 claims
- 4982US2025228860A1Method of treatment of attention deficit/hyperactivity disorder (adhd)SUPERNUS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 5079US10201547B2Method of treatment of aggressionSUPERNUS PHARMACEUTICALS INC·Filed 2018·Granted Feb 12, 2019·1 cites·6 claims
Showing the top 50 of 97 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →